Edition:
United Kingdom

People: Celyad SA (CYAD.BR)

CYAD.BR on Brussels Stock Exchange

12.40EUR
4:36pm BST
Change (% chg)

€-0.06 (-0.48%)
Prev Close
€12.46
Open
€12.30
Day's High
€12.56
Day's Low
€12.28
Volume
30,982
Avg. Vol
38,224
52-wk High
€27.72
52-wk Low
€9.52

Moore, Anne 

Dr. Anne Moore is Vice President Corporate Strategy of the company. Dr. Moore brings to Celyad over 12 years of global experience in strategy consulting and investment banking. Prior to joining Celyad, Dr. Moore served as vice president of healthcare investment banking at Bryan, Garnier & Co., leading numerous equity financings and strategic engagements for clients across Europe and the United States. She also spent eight years in New York working with organizations such as Credit Suisse, Huron Consulting Group and Bionest Partners where she advised mid-sized biotech to larger pharma companies on product launches, marketing, patient services, messaging and branding. Previously, she worked in management consulting in Paris, assisting start-ups shape growth strategies and get their message across. Anne holds a PhD in Human Genetics and Physiology from the Paris XII University and an Advanced Masters in Biotechnology Management from Toulouse Business School

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --